Phase 1 Advanced Soft Tissue Sarcoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Metastatic Soft Tissue SarcomaMetastatic LeiomyosarcomaAdvanced Soft Tissue Sarcoma+5 more

National Cancer Institute (NCI)74 enrolled1 locationNCT06498648

Recruiting

Phase 1

Actinium Therapy for Late-stage Aggressive Sarcomas

Advanced Soft Tissue Sarcoma

Ratio Therapeutics, Inc.30 enrolled6 locationsNCT07156565

Recruiting

Phase 1Phase 2

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

Metastatic Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma

Sarcoma Oncology Research Center, LLC250 enrolled1 locationNCT03138161